We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Depomed, Inc. announced that it has signed a collaboration agreement with Patheon Inc., a leading global provider of development and manufacturing services in the pharmaceutical industry, related to Depomed's proprietary AcuForm drug delivery technology.
Savient Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in developing, manufacturing, and marketing pharmaceutical products that address unmet medical needs, announced that it has completed the sale of its wholly-owned subsidiary, Rosemont Pharmaceuticals Ltd, to an entity affiliated with Close Brothers Private Equity for $176 million.
Neurologix, Inc., a biotech company committed to developing innovative gene therapies for the brain and central nervous system, announced that it has entered into a licensing agreement with a subsidiary of Diamyd Medical, a biotechnology company based in Stockholm, Sweden, and Pittsburgh, PA.
Albemarle Corporation, one of the world's leading producers of bulk ibuprofen, will increase the price of its bulk ibuprofen by a minimum of 20 percent in Western Europe and in the United States for spot purchases effective September 1, 2006, and as contracts allow.
Troubles continue for Neurocrine Biosciences in the wake of a regulatory delay of the insomnia drug indiplon as the company announced it is eliminating its sales staff.
Months of negotiations have come to an end as the top Republican and Democrat on the Senate Health, Education, Labor and Pensions (HELP) Committee finally introduced their comprehensive overhaul of the nation's drug safety efforts.